TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ROIV

Roivant Sciences Ltd

Healthcare · Biotechnology

40.00$ +1.0% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Roivant Sciences Ltd (ROIV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Revenue" came in at 8.3 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ROIV
Line item 2019 2020 2021 2022 2023 2024 2025 2026
2.3 68 24 55 32 33 29 8.3
0.6 1.1 2.1 9.0 3.0 1.6 0.9 1.3
1.7 67 22 46 28 31 28 7.0
513 263 237 483 454 440 550 682
237 336 260 775 383 416 591 610
750 599 1,093 1,258 838 856 1,142 1,292
-748 -532 -1,071 -1,212 -809 -825 -1,114 -1,285
7.5 7.7 2.8 7.0 28 35
-807 -561 -899 -924 -885 4,568 -682 -265
2.6 7.1 1.7 0.4 4.1 22 48 133
-1,042 1,201 -809 -845 -1,009 4,349 -172 -300
138 -553 -896 -911 -838 4,625 -668 -261

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?